220 related articles for article (PubMed ID: 35688320)
1. Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer.
Tosti E; Almeida AS; Tran TTT; Barbachan E Silva M; Broin PÓ; Dubin R; Chen K; Beck AP; Mclellan AS; Vilar E; Golden A; O'Toole PW; Edelmann W
Cell Mol Gastroenterol Hepatol; 2022; 14(3):693-717. PubMed ID: 35688320
[TBL] [Abstract][Full Text] [Related]
2. An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.
Kucherlapati MH; Lee K; Nguyen AA; Clark AB; Hou H; Rosulek A; Li H; Yang K; Fan K; Lipkin M; Bronson RT; Jelicks L; Kunkel TA; Kucherlapati R; Edelmann W
Gastroenterology; 2010 Mar; 138(3):993-1002.e1. PubMed ID: 19931261
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability: an update.
Yamamoto H; Imai K
Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
[TBL] [Abstract][Full Text] [Related]
5. Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome.
Lang M; Baumgartner M; Rożalska A; Frick A; Riva A; Jarek M; Berry D; Gasche C
Int J Cancer; 2020 Oct; 147(8):2316-2326. PubMed ID: 32350866
[TBL] [Abstract][Full Text] [Related]
6. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
[TBL] [Abstract][Full Text] [Related]
7. TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
Fricke F; Lee J; Michalak M; Warnken U; Hausser I; Suarez-Carmona M; Halama N; Schnölzer M; Kopitz J; Gebert J
Cell Commun Signal; 2017 Apr; 15(1):14. PubMed ID: 28376875
[TBL] [Abstract][Full Text] [Related]
8. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.
Poulogiannis G; Frayling IM; Arends MJ
Histopathology; 2010 Jan; 56(2):167-79. PubMed ID: 20102395
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
[TBL] [Abstract][Full Text] [Related]
10. Acetaldehyde and defective mismatch repair increase colonic tumours in a Lynch syndrome model with Aldh1b1 inactivation.
Cerretelli G; Zhou Y; Müller MF; Adams DJ; Arends MJ
Dis Model Mech; 2023 Aug; 16(8):. PubMed ID: 37395714
[TBL] [Abstract][Full Text] [Related]
11. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.
Bommi PV; Bowen CM; Reyes-Uribe L; Wu W; Katayama H; Rocha P; Parra ER; Francisco-Cruz A; Ozcan Z; Tosti E; Willis JA; Wu H; Taggart MW; Burks JK; Lynch PM; Edelmann W; Scheet PA; Wistuba II; Sinha KM; Hanash SM; Vilar E
Cancer Res; 2021 May; 81(10):2760-2773. PubMed ID: 34003775
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
[TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
14. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
[TBL] [Abstract][Full Text] [Related]
15. Ethanol-induced formation of colorectal tumours and precursors in a mouse model of Lynch syndrome.
Cerretelli G; Zhou Y; Müller MF; Adams DJ; Arends MJ
J Pathol; 2021 Dec; 255(4):464-474. PubMed ID: 34543445
[TBL] [Abstract][Full Text] [Related]
16. Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
Vyas M; Firat C; Hechtman JF; Weiser MR; Yaeger R; Vanderbilt C; Benhamida JK; Keshinro A; Zhang L; Ntiamoah P; Gonzalez M; Andrade R; El Dika I; Markowitz AJ; Smith JJ; Garcia-Aguilar J; Vakiani E; Klimstra DS; Stadler ZK; Shia J
Fam Cancer; 2021 Jul; 20(3):201-213. PubMed ID: 33033905
[TBL] [Abstract][Full Text] [Related]
17. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
[TBL] [Abstract][Full Text] [Related]
19. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.
Ten Broeke SW; van Bavel TC; Jansen AML; Gómez-García E; Hes FJ; van Hest LP; Letteboer TGW; Olderode-Berends MJW; Ruano D; Spruijt L; Suerink M; Tops CM; van Eijk R; Morreau H; van Wezel T; Nielsen M
Gastroenterology; 2018 Sep; 155(3):844-851. PubMed ID: 29758216
[TBL] [Abstract][Full Text] [Related]
20. Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.
Aslanian HR; Burgart LJ; Harrington JJ; Mahoney DW; Zinsmeister AR; Thibodeau SN; Ahlquist DA
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1385-8. PubMed ID: 18639494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
